The Scottish Medicines Consortium (SMC) has accepted tebentafusp (Kimmtrak, Immunocore Ltd) for use within NHS Scotland as monotherapy for adults with HLA-A*02:01-positive unresectable or metastatic ...
Learn about notable updates that occurred in June 2026 for investigational products in development (not an inclusive list).
Background Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal cancers due to its aggressive biology and ...
Zacks Small Cap Research on MSN
ESLA: Can Next-Generation CAR-T Therapy Improve Disease Control in Extranodal Lymphoma?
By David Bautz, PhD NASDAQ: ESLA READ THE FULL ESLA RESEARCH REPORT Business Update ARTEMIS Platform Potential in Treating Extramedullary Disease Extramedullary disease (EMD) remains one of the most ...
Background Pancreatic ductal adenocarcinoma (PDAC) is largely refractory to immune checkpoint blockade, owing to its ...
FDA Drug Approvals and Regulatory Updates Drug Pharmacologic class Indication More information Cardiovascular Disease Tryngolza (olezarsen) Apolipoprotein C-III-directed antisense oligonucleotide ...
Vietnam Investment Review on MSN
Leads Biolabs gets six studies selected for ESMO 2026
NANJING, China, July 13, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that six of its latest research studies have been ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results